Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several companies, including Oracle, Boot Barn, Terns Pharmaceuticals, Johnson Controls, Rubrik, Costco, IDEAYA Biosciences, Axon Enterprise, Equity Residential, and News Corporation. Notable changes include TD Cowen raising Oracle's price target to $180 and B of A Securities upgrading Johnson Controls to Buy.
September 10, 2024 | 12:37 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Redburn Atlantic raised Costco's price target from $860 to $890 but downgraded the stock from Buy to Neutral. Shares gained 2.3% to $896.49.
The downgrade to Neutral offsets the positive impact of the raised price target, resulting in a neutral short-term outlook.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEUTRAL IMPACT
BMO Capital cut Rubrik's price target from $40 to $38, maintaining an Outperform rating. Shares rose 4.4% to $32.06.
Despite the price target cut, the Outperform rating and recent share price increase suggest a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Baird increased Axon Enterprise's price target from $360 to $400, maintaining an Outperform rating. Shares gained 2.8% to $364.39.
The raised price target and Outperform rating indicate a positive short-term outlook for Axon Enterprise.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
BTIG raised Boot Barn's price target from $150 to $165, maintaining a Buy rating. Shares gained 3% to $139.55.
The raised price target and Buy rating from BTIG indicate a positive sentiment, likely supporting further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Deutsche Bank boosted Equity Residential's price target from $62 to $83 and upgraded the stock from Hold to Buy. Shares gained 1% to $75.10.
The upgrade to Buy and significant price target increase suggest a positive short-term impact for Equity Residential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Stifel raised IDEAYA Biosciences' price target from $63 to $68, maintaining a Buy rating. Shares rose 0.7% to $36.45.
The increased price target and Buy rating suggest a positive short-term outlook for IDEAYA Biosciences.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
B of A Securities raised Johnson Controls' price target from $76 to $80 and upgraded the stock from Neutral to Buy. Shares gained 1.1% to $68.60.
The upgrade to Buy and increased price target by B of A Securities are likely to drive positive short-term sentiment for Johnson Controls.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Loop Capital raised News Corporation's price target from $38 to $39, maintaining a Buy rating. Shares gained 0.1% to $26.60.
The slight increase in price target and maintained Buy rating suggest a modest positive short-term outlook for News Corporation.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
TD Cowen raised Oracle's price target from $165 to $180, maintaining a Buy rating. Oracle shares fell 1.4% to $139.89.
The increase in price target by TD Cowen suggests a positive outlook for Oracle, which could lead to a short-term price increase despite the recent drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
JMP Securities raised Terns Pharmaceuticals' price target from $15 to $20, maintaining a Market Outperform rating. Shares gained 16.8% to $9.12.
The significant price target increase and strong rating suggest continued positive momentum for Terns Pharmaceuticals.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100